查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1468495

口服蛋白質和胜肽市場按藥物類型（利那洛肽、普萊卡那肽、降鈣素、胰島素、奧曲肽）、應用（胃和消化疾病、骨骼疾病、糖尿病、荷爾蒙失調）和地區2024-2032

Oral Proteins and Peptides Market by Drug Type (Linaclotide, Plecanatide, Calcitonin, Insulin, Octreotide), Application (Gastric and Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球口服蛋白和胜肽市場規模達到17億美元。慢性病盛行率不斷擴大、老年人口不斷增加以及消費者對口服藥物的日益偏好是推動市場發展的一些關鍵因素。

蛋白質和胜肽是人體的天然成分，在許多生物過程中發揮重要作用。由於其結構複雜且易於在胃和小腸中消化，因此通常透過注射給藥。然而，口服蛋白質和胜肽可以透過口服途徑攝取來治療荷爾蒙、胃和代謝紊亂。它們旨在透過使用專門的配方來克服這些挑戰，這些配方可以保護分子免受消化，並允許它們透過腸壁吸收到血液中。這些製劑包括腸溶衣、奈米顆粒和其他遞送技術。口服蛋白質和胜肽廣泛用於治療多種慢性疾病，例如糖尿病、癌症和自體免疫疾病。

口服蛋白質和胜肽市場趨勢：

患有癌症、糖尿病、心血管疾病（CVD）和後天免疫缺乏症候群（AID）等慢性疾病的患者數量不斷增加，以及老年人口的不斷擴大，是推動口服蛋白質和胜肽市場成長的關鍵因素。除此之外，大眾偏好的轉變以及對有效口服藥物和技術的需求不斷成長也促進了市場的成長。此外，消費者健康意識的不斷增強以及對口服蛋白質和胜肽補充劑的眾多益處的認知不斷增強，正在為市場創造積極的前景。除此之外，3D（3D）列印、奈米技術和基因工程等創新技術進步使製造商能夠生產更先進、更具成本效益的產品變體，這是另一個重要的成長誘導因素。同時，製藥公司之間的廣泛合作、醫療保健基礎設施的重大進步以及不斷增加的研發 (R&D) 活動為市場帶來了豐厚的成長機會。此外，消費者可支配收入的增加，富含蛋白質的飲食的廣泛採用，對蛋白粉、蛋白棒和奶昔的需求激增，以及提供便捷產品獲取的在線平台的日益增多，都有助於市場擴張。

本報告回答的關鍵問題：

  • 迄今為止，全球口服蛋白質和胜肽市場表現如何，未來幾年將如何表現？
  • 全球口服蛋白和胜肽市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球口服蛋白質和胜肽市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的口服蛋白質和胜肽市場？
  • 根據藥物類型分類的市場是怎麼樣的？
  • 口服蛋白質和胜肽市場中最具吸引力的藥物類型是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 口服蛋白質和胜肽市場中哪一個應用最有吸引力？
  • 全球口服蛋白和胜肽市場的競爭結構如何？
  • 全球口服蛋白質和胜肽市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球口服蛋白質與胜肽市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依藥物類型

  • 利那洛肽
    • 市場走向
    • 市場預測
  • 普卡那肽
    • 市場走向
    • 市場預測
  • 降鈣素
    • 市場走向
    • 市場預測
  • 胰島素
    • 市場走向
    • 市場預測
  • 奧曲肽
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按應用

  • 胃和消化系統疾病
    • 市場走向
    • 市場預測
  • 骨骼疾病
    • 市場走向
    • 市場預測
  • 糖尿病
    • 市場走向
    • 市場預測
  • 荷爾蒙失調
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 9 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Amryt Pharma Plc
    • AstraZeneca PLC
    • Biocon Limited
    • Novo Nordisk A/S
    • Oramed Ltd
    • Proxima Concepts Limited
Product Code: SR112024A7530

The global oral proteins and peptides market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.51% during 2024-2032. The expanding prevalence of chronic diseases, the rising geriatric population, and the increasing preference for oral drugs among consumers represent some of the key factors driving the market.

Proteins and peptides are natural components of the human body and play essential roles in many biological processes. Due to their complex structure and susceptibility to digestion in the stomach and small intestine, they are usually administered through injections. However, oral proteins and peptides can be taken via the oral path to treat hormonal, gastric, and metabolic disorders. They are designed to overcome these challenges by using specialized formulations that protect the molecules from digestion and allow them to be absorbed through the intestinal wall into the bloodstream. These formulations include enteric coatings, nanoparticles, and other delivery technologies. Oral proteins and peptides are extensively utilized to treat numerous chronic diseases, such as diabetes, cancer, and autoimmune disorders.

Oral Proteins and Peptides Market Trends:

The increasing volume of patients suffering from chronic diseases, such as cancer, diabetes, cardiovascular disorders (CVDs), and acquired immunodeficiency syndrome (AIDs), and the expanding geriatric population represent the key factors driving the oral proteins and peptides market growth. Besides this, shifting preferences and the rising demand for effective oral drugs and technology among the masses are contributing to the market growth. Moreover, the escalating consumer health consciousness and the growing awareness of the numerous benefits associated with the consumption of oral protein and peptide supplements are creating a positive outlook for the market. In addition to this, innovative technological advancements, such as three-dimensional (3D) printing, nanotechnology, and genetic engineering, have enabled manufacturers to produce more advanced and cost-effective product variants, which is acting as another significant growth-inducing factor. Concurrent with this, the extensive collaborative efforts between pharmaceutical companies, significant advancements in the healthcare infrastructure, and rising research and development (R&D) activities are presenting remunerative growth opportunities for the market. Furthermore, the inflating disposable income of consumers, the widespread adoption of protein-rich diets, the surging demand for protein powder, bars, and shakes, and the increasing proliferation of online platforms providing easy product access are aiding in market expansion.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global oral proteins and peptides market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on drug type and application.

Drug Type Insights:

Linaclotide

Plecanatide

Calcitonin

Insulin

Octreotide

The report has provided a detailed breakup and analysis of the oral proteins and peptides market based on the drug type. This includes linaclotide, plecanatide, calcitonin, insulin, and octreotide. According to the report, insulin represented the largest segment.

Application Insights:

Gastric and Digestive Disorders

Bone Diseases

Diabetes

Hormonal Disorders

A detailed breakup and analysis of the oral proteins and peptides market based on the application has also been provided in the report. This includes gastric and digestive disorders, bone diseases, diabetes, and hormonal disorders. According to the report, diabetes accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for oral proteins and peptides. Some of the factors driving the North America oral proteins and peptides market included the increasing prevalence of chronic diseases, the shifting consumer preference for oral drugs, and innovative product advancements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global oral proteins and peptides market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Amryt Pharma Plc, AstraZeneca PLC, Biocon Limited, Novo Nordisk A/S, Oramed Ltd, Proxima Concepts Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global oral proteins and peptides market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global oral proteins and peptides market?
  • What is the impact of each driver, restraint, and opportunity on the global oral proteins and peptides market?
  • What are the key regional markets?
  • Which countries represent the most attractive oral proteins and peptides market?
  • What is the breakup of the market based on the drug type?
  • Which is the most attractive drug type in the oral proteins and peptides market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the oral proteins and peptides market?
  • What is the competitive structure of the global oral proteins and peptides market?
  • Who are the key players/companies in the global oral proteins and peptides market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oral Proteins and Peptides Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 Linaclotide
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Plecanatide
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Calcitonin
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Insulin
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Octreotide
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Gastric and Digestive Disorders
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bone Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diabetes
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Hormonal Disorders
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Amryt Pharma Plc
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 AstraZeneca PLC
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Biocon Limited
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Novo Nordisk A/S
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Oramed Ltd
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Proxima Concepts Limited
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Oral Proteins and Peptides Market: Major Drivers and Challenges
  • Figure 2: Global: Oral Proteins and Peptides Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Oral Proteins and Peptides Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Oral Proteins and Peptides Market: Breakup by Drug Type (in %), 2023
  • Figure 5: Global: Oral Proteins and Peptides Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Oral Proteins and Peptides Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Oral Proteins and Peptides (Linaclotide) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Oral Proteins and Peptides (Linaclotide) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Oral Proteins and Peptides (Plecanatide) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Oral Proteins and Peptides (Plecanatide) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Oral Proteins and Peptides (Calcitonin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Oral Proteins and Peptides (Calcitonin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Oral Proteins and Peptides (Insulin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Oral Proteins and Peptides (Insulin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Oral Proteins and Peptides (Octreotide) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Oral Proteins and Peptides (Octreotide) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Oral Proteins and Peptides (Gastric and Digestive Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Oral Proteins and Peptides (Gastric and Digestive Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Oral Proteins and Peptides (Bone Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Oral Proteins and Peptides (Bone Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Oral Proteins and Peptides (Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Oral Proteins and Peptides (Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Oral Proteins and Peptides (Hormonal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Oral Proteins and Peptides (Hormonal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: North America: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: North America: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: United States: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: United States: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Canada: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Canada: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Asia-Pacific: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Asia-Pacific: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: China: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: China: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Japan: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Japan: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: India: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: India: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: South Korea: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: South Korea: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Australia: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Australia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Indonesia: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Indonesia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Others: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Europe: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Europe: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Germany: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Germany: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: France: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: France: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: United Kingdom: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: United Kingdom: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Italy: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Italy: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Spain: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Spain: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Russia: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Russia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Others: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Latin America: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Latin America: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Brazil: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Brazil: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Mexico: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Mexico: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Others: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Middle East and Africa: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Middle East and Africa: Oral Proteins and Peptides Market: Breakup by Country (in %), 2023
  • Figure 73: Middle East and Africa: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Global: Oral Proteins and Peptides Industry: Drivers, Restraints, and Opportunities
  • Figure 75: Global: Oral Proteins and Peptides Industry: Value Chain Analysis
  • Figure 76: Global: Oral Proteins and Peptides Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oral Proteins and Peptides Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Oral Proteins and Peptides Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 3: Global: Oral Proteins and Peptides Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Oral Proteins and Peptides Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Oral Proteins and Peptides Market: Competitive Structure
  • Table 6: Global: Oral Proteins and Peptides Market: Key Players